Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB26FH4TS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,551
Award facts
- Contract value 100% obligated
- $5,550.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,550.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 Unit Vials. The award was issued on October 31, 2025, with an ultimate completion date of November 24, 2025, under a firm fixed-price delivery order with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR.
The PPV-G GEN V represents a $30.3 billion acquisition strategy through which the Defense Logistics Agency establishes regional prime vendor contractors to supply a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's IDC under this program carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. The company's demonstrated performance across numerous delivery orders for specialized pharmaceuticals positions it as a critical supplier within the Department of Defense's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FH4TS?
SPE2DB26FH4TS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FH4TS worth?
The government has obligated $5,551 on SPE2DB26FH4TS.
Is contract SPE2DB26FH4TS an order under another contract?
Yes. SPE2DB26FH4TS is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB26FH4TS competed?
The extent of competition for SPE2DB26FH4TS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award